Aurora Cannabis (NASDAQ:ACB - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Investors interested in registering for the company's conference call can do so using this link.
Aurora Cannabis Stock Performance
NASDAQ ACB traded down $0.17 during trading hours on Friday, hitting $3.65. 610,470 shares of the company's stock traded hands, compared to its average volume of 645,899. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The firm has a market capitalization of $200.24 million, a P/E ratio of -4.80 and a beta of 1.86. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The business's fifty day moving average price is $4.23 and its two-hundred day moving average price is $5.19.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on ACB shares. TD Securities raised shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. TD Cowen started coverage on Aurora Cannabis in a report on Wednesday, December 11th. They set a "buy" rating for the company.
View Our Latest Report on Aurora Cannabis
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
